We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The catheter uses a dynamic cage to separate clots from vessel walls while simultaneously drawing clots into itself, macerating them and transporting them out of the body. Read More
The FDA said the device’s transvaginal approach reduces the number of incisions needed on the abdomen compared to conventional laparoscopic hysterectomy. Read More
More than 100 participants have achieved the trial’s primary endpoint, which is measuring the rate of overall clinical success at 24 months, Empirical Spine said. Read More
The test features a “pretreatment process” that inactivates the virus without compromising test quality or validity, helping to protect staff from infection. Read More
Despite — or in part because of — COVID-19 challenges, the FDA’s Center for Devices and Radiological Health (CDRH) cleared a record 132 novel devices in 2020, surpassing its previous record of 106 in 2018. Read More
When the device’s hemostat powder makes contact with blood or fluid in the gastrointestinal tract, a gelled matrix forms to provide a barrier that helps to further control bleeding, the company said. Read More
The company said the system’s closed-loop stimulation feature, which automatically adjusts to patients’ individual needs, is currently in clinical evaluation. Read More
The diagnostic is designed for professional use as a point-of-care test in clinical and non-clinical settings, including healthcare centers, travel hubs, educational institutions and businesses, PerkinElmer said. Read More